ETF Exchange > BBH ETF
BBH - ETF Fact Sheet
VanEck Biotech ETF - USD
Fund Identification
Ticker
BBH
ISIN
US92189F7261
Main Metrics
Price
$204.74Expense Ratio
0.35%AuM
$398.53MTracking Difference
-0.13%Ratings
Trackinsight rating
★★★★★Official Investment Strategy
VanEck Vectors® Biotech ETF (BBH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Biotech 25 Index (MVBBHTR), which is intended to track the overall performance of companies involved in the development and production, marketing and sales of drugs based on genetic analysis and diagnostic equipment.
BBH's historical prices, performance, and flows
1m returns
8.93%
1m flows
-$0M
* Net total returns
All data as of 17 July 2026
The ETF Exchange is brought to you by
With data and analysis by
See all BBH data with a
free P&I Online account
free P&I Online account
Enjoy unlimited ETF searches and access to tear-sheets of over 4,000 North-American funds.
or Login
BBH's characteristics
Manager
Manager statistics
193 funds, $219.77Bn in AUM
Benchmark
MVIS US Listed Biotech 25 Net Total Return Index - USD
Replication method
Direct (Physical)
Asset class
Equity
Dividend policy
Distributing
BBH's exposure
Countries
USA
85.88%
Netherlands
7.11%
Other
7.01%
Sectors
Healthcare
100.00%
Top 5 holdings
Gilead Sciences, Inc.
14.30%
Amgen, Inc.
13.90%
Vertex Pharmaceuticals, Inc.
8.09%
argenx SE
6.06%
Regeneron Pharmaceuticals, Inc.
6.04%
Total holdings
24
Total weight of top 5
48.39%
